<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK541730" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK541730/" /><meta name="ncbi_pagename" content="Gabriele-de Vries Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Gabriele-de Vries Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Gabriele-de Vries Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/05/30" /><meta name="citation_author" content="Maria J Nabais Sá" /><meta name="citation_author" content="Michele Gabriele" /><meta name="citation_author" content="Giuseppe Testa" /><meta name="citation_author" content="Bert BA de Vries" /><meta name="citation_pmid" content="31145572" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK541730/" /><meta name="citation_keywords" content="YY1 Intellectual Disability Syndrome" /><meta name="citation_keywords" content="YY1 Intellectual Disability Syndrome" /><meta name="citation_keywords" content="Transcriptional repressor protein YY1" /><meta name="citation_keywords" content="YY1" /><meta name="citation_keywords" content="Gabriele-de Vries Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Gabriele-de Vries Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Maria J Nabais Sá" /><meta name="DC.Contributor" content="Michele Gabriele" /><meta name="DC.Contributor" content="Giuseppe Testa" /><meta name="DC.Contributor" content="Bert BA de Vries" /><meta name="DC.Date" content="2019/05/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK541730/" /><meta name="description" content="Gabriele-de Vries syndrome is characterized by mild-to-profound developmental delay / intellectual disability (DD/ID) in all affected individuals and a wide spectrum of functional and morphologic abnormalities. Intrauterine growth restriction or low birth weight and feeding difficulties are common. Congenital brain, eye, heart, kidney, genital, and/or skeletal system anomalies have also been reported. About half of affected individuals have neurologic manifestations, including hypotonia and gait abnormalities. Behavioral issues can include attention-deficit/hyperactivity disorder, anxiety, autism or autistic behavior, and schizoaffective disorder." /><meta name="og:title" content="Gabriele-de Vries Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Gabriele-de Vries syndrome is characterized by mild-to-profound developmental delay / intellectual disability (DD/ID) in all affected individuals and a wide spectrum of functional and morphologic abnormalities. Intrauterine growth restriction or low birth weight and feeding difficulties are common. Congenital brain, eye, heart, kidney, genital, and/or skeletal system anomalies have also been reported. About half of affected individuals have neurologic manifestations, including hypotonia and gait abnormalities. Behavioral issues can include attention-deficit/hyperactivity disorder, anxiety, autism or autistic behavior, and schizoaffective disorder." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK541730/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gabriele-devries/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK541730/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A41D6E04093C1000000000678026A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK541730_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK541730_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/drd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gaucher/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK541730_"><span class="title" itemprop="name">Gabriele-de Vries Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: <i>YY1</i> Intellectual Disability Syndrome</div><p class="contrib-group"><span itemprop="author">Maria J Nabais S&#x000e1;</span>, MD, MPH, PhD, <span itemprop="author">Michele Gabriele</span>, MS, PhD, <span itemprop="author">Giuseppe Testa</span>, MD, PhD, MA, and <span itemprop="author">Bert BA de Vries</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK541730_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK541730_ai__"><div class="contrib half_rhythm"><span itemprop="author">Maria J Nabais S&#x000e1;</span>, MD, MPH, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@assiaban.airam" class="oemail">ln.cmuduobdar@assiaban.airam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Michele Gabriele</span>, MS, PhD<div class="affiliation small">Laboratory of Stem Cell Epigenetics<br />Department of Experimental Oncology, IEO<br />European Institute of Oncology IRCCS<br />Milan, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.oei@eleirbag.elehcim" class="oemail">ti.oei@eleirbag.elehcim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Giuseppe Testa</span>, MD, PhD, MA<div class="affiliation small">Laboratory of Stem Cell Epigenetics<br />Department of Experimental Oncology, IEO<br />European Institute of Oncology IRCCS<br />Milan, Italy</div><div class="affiliation small">Department of Oncology and Hemato-Oncology<br />University of Milan<br />Milan, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.iminu@atset.eppesuig" class="oemail">ti.iminu@atset.eppesuig</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ti.oei@atset.eppesuig" class="oemail">ti.oei@atset.eppesuig</a><div></div></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bert BA de Vries</span>, MD, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@seirved.treb" class="oemail">ln.cmuduobdar@seirved.treb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 30, 2019</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gabriele-devries.Summary" itemprop="description"><h2 id="_gabriele-devries_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Gabriele-de Vries syndrome is characterized by mild-to-profound developmental delay / intellectual disability (DD/ID) in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and a wide spectrum of functional and morphologic abnormalities. Intrauterine growth restriction or low birth weight and feeding difficulties are common. Congenital brain, eye, heart, kidney, genital, and/or skeletal system anomalies have also been reported. About half of affected individuals have neurologic manifestations, including hypotonia and gait abnormalities. Behavioral issues can include attention-deficit/hyperactivity disorder, anxiety, autism or autistic behavior, and schizoaffective disorder.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Gabriele-de Vries syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involving <i>YY1</i> or a heterozygous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 14q32.2 involving only <i>YY1</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Developmental delay / intellectual disability, craniofacial anomalies (Pierre Robin sequence, cleft palate, craniosynostosis, abnormalities of the lacrimal duct), feeding difficulties, gastroesophageal reflux, constipation, seizures, behavioral manifestations, strabismus, refractive error, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, renal anomalies, cryptorchidism, and skeletal anomalies are treated per standard practice.</p><p><i>Surveillance:</i> Of clinical manifestations as clinically indicated.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Gabriele-de Vries syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. All probands reported to date with Gabriele-de Vries syndrome whose parents have undergone <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. Risk to future pregnancies is presumed to be low as the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> most likely has a <i>de novo YY1</i> pathogenic variant or deletion; however, given the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated at 1%, and thus prenatal testing for pregnancies at risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> may be considered.</p></div></div><div id="gabriele-devries.Diagnosis"><h2 id="_gabriele-devries_Diagnosis_">Diagnosis</h2><p>No formal clinical diagnostic criteria exist for Gabriele-de Vries syndrome.</p><div id="gabriele-devries.Suggestive_Findings"><h3>Suggestive Findings</h3><p>The clinical spectrum of Gabriele-de Vries syndrome is variable. Gabriele-de Vries syndrome <b>should be considered</b> in individuals presenting with the following clinical findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Mild-to-profound developmental delay <b>and/or</b> intellectual disability; AND</div></li><li class="half_rhythm"><div>Any of the following features presenting in infancy or childhood:</div><ul><li class="half_rhythm"><div>Craniofacial dysmorphisms (see <a href="#gabriele-devries.Clinical_Description">Clinical Description</a>)</div></li><li class="half_rhythm"><div>Intrauterine growth restriction / low birth weight</div></li><li class="half_rhythm"><div>Feeding difficulties</div></li><li class="half_rhythm"><div>Neurologic abnormalities (hypotonia, abnormalities of movement, gait abnormalities)</div></li><li class="half_rhythm"><div>Behavioral problems (attention-deficit/hyperactivity disorder, anxiety, autism or autistic behavior, schizoaffective disorder)</div></li><li class="half_rhythm"><div>Congenital brain, eye, heart, kidney, genital, and/or skeletal system anomalies (see <a href="#gabriele-devries.Clinical_Description">Clinical Description</a>)</div></li></ul></li></ul></div><div id="gabriele-devries.Establishing_the_Diagno"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Gabriele-de Vries syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has <b>one of the following</b> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK541730/table/gabriele-devries.T.molecular_genetic_tes/?report=objectonly" target="object" rid-figpopup="figgabrieledevriesTmoleculargenetictes" rid-ob="figobgabrieledevriesTmoleculargenetictes">Table 1</a>):</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involving <i>YY1</i></div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 14q32.2 involving <i>YY1</i> only</div></li></ul><p>Note: See <a href="#gabriele-devries.Genetically_Related_All">Genetically Related Disorders</a> for information about deletions of 14q32.2 that involve <i>YY1</i> and other, adjacent genes.</p><p><b>Molecular genetic testing</b> in a child with developmental delay or an older individual with intellectual disability typically begins with <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA). If CMA is not diagnostic, the next step is typically either a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>. Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of<i>YY1</i>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Chromosomal microarray analysis (CMA)</b> uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>YY1</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div><div class="half_rhythm">Note: To date, most individuals with a <i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have been identified by CMA performed in the context of evaluation for developmental delay, intellectual disability, or autism spectrum disorder; however, many CMA platforms do not include sufficient coverage for this region and thus a <i>YY1</i> deletion may not be detected.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>An intellectual disability (ID) <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>YY1</i> and other genes of interest (see <a href="#gabriele-devries.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition in a person with a non-diagnostic CMA at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of <i>YY1</i>, some panels for ID may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder an ID multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK541730/table/gabriele-devries.T.molecular_genetic_tes/?report=objectonly" target="object" rid-figpopup="figgabrieledevriesTmoleculargenetictes" rid-ob="figobgabrieledevriesTmoleculargenetictes">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Exome sequencing,</b> which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is likely involved, yields results similar to an ID <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> but has two advantages: (1) a multigene panel may not include all rare genes recently identified as causing ID; and (2) <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> may be able to detect pathogenic variants in genes that &#x02013; for technical reasons &#x02013; do not sequence well.</div><div class="half_rhythm">If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic &#x02013; and particularly when evidence supports <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="gabriele-devries.T.molecular_genetic_tes" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Gabriele-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541730/table/gabriele-devries.T.molecular_genetic_tes/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gabriele-devries.T.molecular_genetic_tes_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>YY1</i></td><td headers="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/10&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5,&#x000a0;6</sup></td><td headers="hd_h_gabriele-devries.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>4,&#x000a0;7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gabriele-devries.TF.1.1"><p class="no_margin">See <a href="/books/NBK541730/#gabriele-devries.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="gabriele-devries.TF.1.2"><p class="no_margin">See <a href="#gabriele-devries.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="gabriele-devries.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="gabriele-devries.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="gabriele-devries.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. Gene-targeted deletion/duplication testing will detect deletions ranging from a single exon to the whole gene; however, breakpoints of large deletions and/or deletion of adjacent genes (e.g., those described by <a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al [2017]</a>) may not be detected by these methods.</p></div></dd><dt>6. </dt><dd><div id="gabriele-devries.TF.1.6"><p class="no_margin">Targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> testing is not appropriate for an individual in whom a pathogenic <i>YY1</i> deletion was not detected by CMA designed to target chr14:100,705,102-100,745,371 region (GRCh37).</p></div></dd><dt>7. </dt><dd><div id="gabriele-devries.TF.1.7"><p class="no_margin">Chromosomal microarray analysis (CMA) uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including<i>YY1</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. Approximately 13 individuals who have larger deletions of 14q32.2 that include <i>YY1</i> and other, adjacent genes have been identified through CMA analysis (see <a href="#gabriele-devries.Genetically_Related_All">Genetically Related Disorders</a>) [<a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al 2017</a>].</p></div></dd></dl></div></div></div></div></div><div id="gabriele-devries.Clinical_Characteristic"><h2 id="_gabriele-devries_Clinical_Characteristic_">Clinical Characteristics</h2><div id="gabriele-devries.Clinical_Description"><h3>Clinical Description</h3><p>To date, ten individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic <i>YY1</i> variant have been described with an overlapping <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#gabriele-devries.REF.vissers.2010.1109">Vissers et al 2010</a>, <a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al 2017</a>]. <i>De novo</i>
<i>YY1</i> variants result in <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> ID with a wide spectrum of functional and morphologic abnormalities, in particular intrauterine growth restriction or low birth weight, feeding difficulties, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies, nonspecific craniofacial dysmorphism, and neurologic and behavioral abnormalities.</p><p><b>Developmental delay (DD) and intellectual disability (ID).</b> All individuals with a <i>YY1</i> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had DD/ID, which was usually mild (IQ 50-70) to moderate (IQ 35-49). One individual with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>YY1</i> pathogenic variant manifested severe ID.</p><ul><li class="half_rhythm"><div><b>Gross motor skills.</b> The majority of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (8/10) had motor delay and started walking independently between age 15 months and 6.5 years (median age: 2 years). Three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals sat alone at 12 months. Gait disturbances were noticed in two affected individuals, specifically toe walking and waddling gait.</div></li><li class="half_rhythm"><div><b>Language development</b> was delayed in half of the children with a pathogenic <i>YY1</i> variant (5/10). Severity varied between individuals; while two children had mild speech delay, one child used two- to three-word sentences at age seven years and another child, age nine years, did not use verbal communication.</div></li></ul><p><b>Craniofacial features.</b> All individuals described have facial dysmorphisms. The facial gestalt in most of the individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>YY1</i> variant includes the following:</p><ul><li class="half_rhythm"><div>Generalized facial asymmetry, with mild discrepancy in the size of one side of the face compared to the other</div></li><li class="half_rhythm"><div>Broad forehead</div></li><li class="half_rhythm"><div>Fullness of upper eyelids</div></li><li class="half_rhythm"><div>Downslanted palpebral fissures</div></li><li class="half_rhythm"><div>Bulbous nose</div></li><li class="half_rhythm"><div>Malar flattening</div></li><li class="half_rhythm"><div>Indentation of the vermilion of the upper lip resembling a ginkgo leaf</div></li><li class="half_rhythm"><div>Thick vermilion of the lower lip</div></li><li class="half_rhythm"><div>Pointed chin</div></li></ul><p>External ear malformations are common and include the following:</p><ul><li class="half_rhythm"><div>Abnormally shaped ears</div></li><li class="half_rhythm"><div>Simple ears</div></li><li class="half_rhythm"><div>Posteriorly rotated ears</div></li><li class="half_rhythm"><div>Low-set ears</div></li><li class="half_rhythm"><div>Protruding ears</div></li></ul><p>Rare craniofacial findings have included the following:</p><ul><li class="half_rhythm"><div>Abnormalities of the lacrimal duct, specifically lacrimal duct stenosis and hypoplastic lacrimal duct</div></li><li class="half_rhythm"><div>Craniosynostosis in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual (suture not specified)</div></li><li class="half_rhythm"><div>Pierre Robin sequence with a cleft palate in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual</div></li></ul><p><b>Growth.</b> Low birth weight was reported in approximately half of newborns with a <i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (5/9). Later weight was recovered and only two of these individuals maintained persistently low body weight. Short stature was observed in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a pathogenic <i>YY1</i> variant.</p><p><b>Feeding difficulties / gastrointestinal abnormalities.</b> Feeding difficulties occurred often. Oral-pharyngeal dysphagia with chewing and swallowing difficulty may be seen and some individuals require G-tube insertion for feeding problems.</p><p><b>Neurologic abnormalities.</b> About half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had neurologic problems, including hypotonia, abnormalities of movement (1 affected individual with tremor and 2 with progressive dystonia, including torsion dystonia), gait abnormalities, and, rarely, febrile seizures.</p><p><b>Behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</b> Approximately half of the individuals with a pathogenic <i>YY1</i> variant had behavioral problems (5/9), which included attention-deficit/hyperactivity disorder, anxiety, autism or autistic behavior, and schizoaffective disorder. Sleeping problems were described in a minority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (2/9).</p><p><b>Neuroimaging abnormalities.</b> A variety of nonspecific morphologic abnormalities of the central nervous system (CNS) have been described, including the following:</p><ul><li class="half_rhythm"><div>Abnormalities of the subarachnoid space (widened subarachnoid space)</div></li><li class="half_rhythm"><div>Delayed myelination</div></li><li class="half_rhythm"><div>Frontal gliosis</div></li><li class="half_rhythm"><div>Cortical dysplasia</div></li><li class="half_rhythm"><div>Focal areas of encephalomalacia</div></li><li class="half_rhythm"><div>Unilateral and/or bilateral dilation of the lateral ventricles</div></li><li class="half_rhythm"><div>Abnormalities of cerebral white matter (cerebral white matter atrophy, subcortical bifrontal white matter foci)</div></li><li class="half_rhythm"><div>Abnormalities of the corpus callosum (ranging from hypoplasia of the corpus callosum to agenesis of corpus callosum)</div></li></ul><p>Each of the reported CNS morphologic abnormalities was observed in one or two individuals (occurring alone or concomitantly with another neuroimaging abnormality) and is not exclusive to Gabriele-de Vries syndrome.</p><p><b>Congenital anomalies.</b> A variety of structural malformations have been described:</p><ul><li class="half_rhythm"><div><b>Eye abnormalities.</b> Strabismus and abnormalities of refraction (hypermetropia and astigmatism) were present in more than half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div><b>Heart abnormalities.</b> Patent foramen ovale and small aorto-pulmonary collateral has been described in one individual and Ebstein's anomaly of the tricuspid valve in another.</div></li><li class="half_rhythm"><div><b>Renal abnormalities.</b> Hydronephrosis (2/7), occurring concomitantly or not with ureteropelvic junction stenosis (1/7), was reported in a minority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div><b>Genital abnormalities.</b> Bilateral cryptorchidism was unusual, being reported in only one individual (1/5).</div></li><li class="half_rhythm"><div><b>Skeletal abnormalities.</b> The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals manifested abnormalities of the extremities, which varied greatly in location and severity. The following anomalies were present in no more than one individual each:</div><ul><li class="half_rhythm"><div>Unilateral hemihypotrophy of lower limb</div></li><li class="half_rhythm"><div>Patella luxations</div></li><li class="half_rhythm"><div>Increased laxity of fingers</div></li><li class="half_rhythm"><div>Long fingers</div></li><li class="half_rhythm"><div>Sydney crease<sup>*</sup></div></li><li class="half_rhythm"><div>Sandal gap</div></li><li class="half_rhythm"><div>Hallux valgus</div></li><li class="half_rhythm"><div>Distal arthrogryposis</div></li></ul></li></ul><p>*Note: The Sydney crease is a proximal transverse (5-finger) crease that starts on the radial side of the hand near the base of the index finger and extends completely to the ulnar margin of the palm.</p><p><b>Endocrine abnormalities</b> were reported in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and included hypothyroidism in two and growth hormone deficiency in one.</p><p><b>Other.</b> The following features have been observed in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual each, and therefore it is unclear if the finding is related to the diagnosis of Gabriele-De Vries syndrome or is a coincidental finding:</p><ul><li class="half_rhythm"><div>Recurrent infections</div></li><li class="half_rhythm"><div>Breast hypoplasia</div></li><li class="half_rhythm"><div>Hyperextensible skin</div></li><li class="half_rhythm"><div>Childhood-onset neuroblastoma</div></li></ul></div><div id="gabriele-devries.GenotypePhenotype_Corre"><h3>Genotype-Phenotype Correlations</h3><p>Given the small number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported in the literature, no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are currently known.</p></div><div id="gabriele-devries.Prevalence"><h3>Prevalence</h3><p>Gabriele-de Vries syndrome is a rare condition. So far, ten <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals worldwide have been described in the medical literature with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> intragenic <i>YY1</i> variant.</p><p>The prevalence of Gabriele-de Vries syndrome is yet to be determined. To date, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants in <i>YY1</i> were identified in 0.03%&#x02013;1% of individuals with unexplained intellectual disability in diverse studied cohorts with estimates of prevalence varying in different subsets of individuals tested [<a class="bk_pop" href="#gabriele-devries.REF.vissers.2010.1109">Vissers et al 2010</a>, <a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al 2017</a>].</p><p>Since individuals have been recruited via large <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> projects, it is expected that more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals will be diagnosed with Gabriele-de Vries syndrome as the use of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing increases.</p></div></div><div id="gabriele-devries.Genetically_Related_All"><h2 id="_gabriele-devries_Genetically_Related_All_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic intragenic variants in <i>YY1</i>.</p><p><b>Contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions encompassing <i>YY1</i> and adjacent genes.</b> Non-recurrent significantly larger deletions encompassing all or part of <i>YY1</i> and adjacent genes have been described in 13 individuals, resulting in <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> intellectual disability [<a class="bk_pop" href="#gabriele-devries.REF.vissers.2010.1109">Vissers et al 2010</a>, <a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al 2017</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of those with contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions including <i>YY1</i> depends on the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and the specific gene content. Overlapping clinical characteristics observed in individuals with chromosomal deletions encompassing <i>YY1</i> and adjacent genes and those who have solely <i>YY1</i> pathogenic variants include feeding difficulties, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies, nonspecific craniofacial dysmorphism, ophthalmologic abnormalities, and neurologic and behavioral abnormalities. Nevertheless, due to the involvement of numerous additional genes occasionally comprising the UPD(14) gene cluster, <b>larger deletions of 14q32.3 that include <i>YY1</i></b> result in a clinically distinct phenotype, including the following:</p><ul><li class="half_rhythm"><div><b>Prenatal abnormalities.</b> Therapeutic abortion was performed in two pregnancies of fetuses with multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies and larger deletions of 14q32.3 encompassing <i>YY1</i>. One fetus presented with partial esophageal atresia, clubfeet, congenital heart disease (tricuspid regurgitation and right ventricle thickness), and fetal cystic hygroma and the other with agenesis of corpus callosum, enlarged kidneys, and a single umbilical artery. Intrauterine growth restriction was further observed in almost half of individuals (5/11) with larger 14q32.3 deletions that include <i>YY1</i>.</div></li><li class="half_rhythm"><div><b>Craniofacial features.</b> Craniosynostosis (sutures not specified) was seen in four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, one of whom also had a cleft palate.</div></li><li class="half_rhythm"><div><b>Growth.</b> Short stature was observed in two individuals. Head circumference was generally within the normal range; microcephaly occurred in one person.</div></li><li class="half_rhythm"><div><b>Neurologic abnormalities.</b> Hypotonia was observed in approximately half of the individuals. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual manifested spasticity.</div></li><li class="half_rhythm"><div><b>Behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</b> Two individuals were diagnosed with attention-deficit/hyperactivity disorder.</div></li><li class="half_rhythm"><div><b>Heart abnormalities.</b> Two individuals exhibited abnormalities of the cardiac septa, specifically atrial septal defect and atrioventricular septal defect with a hypoplastic aortic arch. One other individual manifested right ventricle thickness and tricuspid regurgitation.</div></li><li class="half_rhythm"><div><b>Renal abnormalities.</b> Duplex kidney, ureteral duplication with vesicoureteric reflux, and enlarged kidneys were detected in three individuals.</div></li><li class="half_rhythm"><div><b>Genital abnormalities.</b> Micropenis was observed in two individuals with a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving <i>YY1</i> and adjacent genes. One of these individuals also had scrotal hypoplasia.</div></li></ul><p><b>Sporadic tumors</b> (including insulinomas) occurring as single tumors in the absence of any other findings of Gabriele-de Vries syndrome frequently harbor somatic variants in <i>YY1</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to these tumors is not heritable. For more information see <a href="#gabriele-devries.Cancer_and_Benign_Tumor">Cancer and Benign Tumors</a>.</p></div><div id="gabriele-devries.Differential_Diagnosis"><h2 id="_gabriele-devries_Differential_Diagnosis_">Differential Diagnosis</h2><p>The phenotypic features associated with Gabriele-de Vries syndrome are not sufficient to diagnose this condition clinically; therefore, all disorders with intellectual disability (ID) and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies should be considered in the differential diagnosis. To date more than 180 such disorders with ID have been identified. See OMIM Phenotypic Series: <a href="https://omim.org/phenotypicSeries/PS156200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Autosomal dominant ID</a>; <a href="https://omim.org/phenotypicSeries/PS249500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Autosomal recessive ID</a>; and <a href="https://omim.org/phenotypicSeries/PS309510" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Syndromic X-linked ID</a>.</p></div><div id="gabriele-devries.Management"><h2 id="_gabriele-devries_Management_">Management</h2><div id="gabriele-devries.Evaluations_and_Referra"><h3>Evaluations and Referrals Following Initial Diagnosis</h3><p>Evaluation by a multidisciplinary team can be beneficial.</p><p>To establish the extent of disease and needs in an individual diagnosed with Gabriele-de Vries syndrome, the evaluations summarized <a class="figpopup" href="/books/NBK541730/table/gabriele-devries.T.recommended_evaluatio/?report=objectonly" target="object" rid-figpopup="figgabrieledevriesTrecommendedevaluatio" rid-ob="figobgabrieledevriesTrecommendedevaluatio">Table 2</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><p>Note: Some evaluations are age dependent and may not be relevant at the time of initial diagnosis.</p><div id="gabriele-devries.T.recommended_evaluatio" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of Gabriele-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541730/table/gabriele-devries.T.recommended_evaluatio/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gabriele-devries.T.recommended_evaluatio_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">System/Concern</th><th id="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodevelopmental</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl evaluation of motor, speech/language, general cognitive, &#x00026; vocational skills</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniofacial</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation for cleft palate &#x00026;/or micrognathia</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to multidisciplinary craniofacial team if cleft palate &#x00026;/or micrognathia is present.&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical assessment for craniosynostosis</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to multidisciplinary craniofacial team for facial asymmetry / abnormal head shape or size.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of growth parameters to identify children w/low birth weight &#x00026;/or short stature</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider endocrinologic evaluation, incl thyroid function tests &#x00026; growth hormone assessment.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of feeding difficulties</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Refer to occupational or speech therapist for feeding therapy.</div></li><li class="half_rhythm"><div>Consider referral to gastroenterologist, if severe, to assess need for gastrostomy tube.</div></li></ul>
</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Assessment for gastroesophageal reflux disease &#x00026; constipation</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to gastroenterologist, if severe.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation&#x000a0;<sup>2</sup></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>W/consideration of EEG &#x00026;/or brain MRI</div></li><li class="half_rhythm"><div>Consider referral to pediatric neurologist.</div></li></ul>
</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Behavioral/</b><br /><b>Psychiatric</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider neuropsychiatric evaluation.</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Screen individuals age &#x0003e;12 mos for behavior concerns incl sleep disturbances, ADHD, anxiety, &#x00026;/or traits suggestive of ASD.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to ophthalmologist.</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For evaluation of strabismus &#x00026;/or refraction errors</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider echocardiography to evaluate for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects.</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to pediatric cardiologist.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider baseline renal ultrasound.</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for renal anomalies</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genital</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation of cryptorchidism or other penile or scrotal anomalies in boys</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to pediatric urologist if cryptorchidism is present.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation for skeletal abnormalities</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to an orthopedist if abnormalities are present.</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/Other</b></td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_gabriele-devries.T.recommended_evaluatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder</p></div></dd><dt>1. </dt><dd><div id="gabriele-devries.TF.2.1"><p class="no_margin">Including plastic surgeons, neurosurgeons, speech pathologists, geneticists, pediatricians, orthodontists, and other craniofacial specialists</p></div></dd><dt>2. </dt><dd><div id="gabriele-devries.TF.2.2"><p class="no_margin">Assessment of hypotonia, movement disorders, gait abnormalities, and history of possible seizures</p></div></dd></dl></div></div></div></div><div id="gabriele-devries.Treatment_of_Manifestat"><h3>Treatment of Manifestations</h3><div id="gabriele-devries.T.treatment_of_manifest" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Gabriele-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541730/table/gabriele-devries.T.treatment_of_manifest/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gabriele-devries.T.treatment_of_manifest_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestation/Concern</th><th id="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Treatment</th><th id="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft palate</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical repair</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Per multidisciplinary craniofacial team&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniosynostosis</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical repair, as needed</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Per a multidisciplinary craniofacial team&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding difficulties</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding therapy &#x00026;/or dietary measures</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gastrostomy tube placement may be required for persistent feeding problems.</td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastroesophageal reflux disease &#x00026;/or constipation</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard management &#x00026; treatment(s)</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a gastroenterologist, if severe.</td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standardized treatment w/antiepileptic drugs (AEDs) by an experienced neurologist&#x000a0;<sup>2</sup></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Many different AEDs may be effective, &#x00026; no one AED has been demonstrated effective specifically for this disorder.</td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Behavioral/psychiatric abnormalities</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Appropriate behavioral management strategies &#x00026;/or psychotropic medications, per psychiatrist</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Strabismus &#x00026;/or refraction abnormalities</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine management for ophthalmologic problems</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital heart defects</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine treatment for cardiac abnormalities</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal structural anomalies</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine management for renal abnormalities</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cryptorchidism</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine management for cryptorchidism</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal anomalies</b></td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as recommended by orthopedist</td><td headers="hd_h_gabriele-devries.T.treatment_of_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gabriele-devries.TF.3.1"><p class="no_margin">Including plastic surgeons, pediatricians, orthodontists, and other craniofacial specialists</p></div></dd><dt>2. </dt><dd><div id="gabriele-devries.TF.3.2"><p class="no_margin">Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div></dd></dl></div></div></div><div id="gabriele-devries.Developmental_Delay__In"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years.</b> In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="gabriele-devries.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="gabriele-devries.SocialBehavioral_Concer"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications, such as medication used to treat ADHD, when necessary.</p></div></div><div id="gabriele-devries.Surveillance"><h3>Surveillance</h3><p>A developmental pediatrician or a geneticist should coordinate the follow up of a child with Gabriele-de Vries syndrome. Surveillance of gastrointestinal, craniofacial, cardiac, renal, genital, skeletal, and endocrine abnormalities should be tailored to the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual according to the specific problems identified at diagnosis.</p><p>Long-term follow up by other specialists is also recommended and includes the following.</p><div id="gabriele-devries.T.recommended_surveilla" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Gabriele-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541730/table/gabriele-devries.T.recommended_surveilla/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gabriele-devries.T.recommended_surveilla_lrgtbl__"><table><thead><tr><th id="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of growth parameters</td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit until adulthood</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor those w/seizures</td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As clinically indicated</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Assessment of neurologic disease progression</td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit beginning in childhood</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric</b></td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Behavioral assessment for anxiety, attention, &#x00026; aggressive or self-injurious behavior</td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit beginning in childhood</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As needed based on symptoms</td></tr><tr><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/Other</b></td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor developmental progress &#x00026; educational needs</td><td headers="hd_h_gabriele-devries.T.recommended_surveilla_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr></tbody></table></div></div></div><div id="gabriele-devries.Evaluation_of_Relatives"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#gabriele-devries.Related_Genetic_Counsel">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gabriele-devries.Therapies_Under_Investi"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="gabriele-devries.Genetic_Counseling"><h2 id="_gabriele-devries_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gabriele-devries.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Gabriele-de Vries syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner and is typically caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="gabriele-devries.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>All probands reported to date with Gabriele-de Vries syndrome whose parents have undergone <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the pathogenic variant most likely occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband. Another possible explanation is that the proband inherited a pathogenic variant from a parent with <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Although theoretically possible, no instances of germline mosaicism have been reported to date.</div></li><li class="half_rhythm"><div>Theoretically, if the parent is the individual in whom the <i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents: if the <i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the proband cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#gabriele-devries.REF.rahbari.2016.126">Rahbari et al 2016</a>].</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with Gabriele-de Vries syndrome are not known to reproduce.</p><p><b>Other family members.</b> Given that all probands with Gabriele-de Vries syndrome reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to other family members is presumed to be low.</p></div><div id="gabriele-devries.Related_Genetic_Counsel"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="gabriele-devries.Prenatal_Testing_and_Pr"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Risk to future pregnancies is presumed to be low as the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> most likely has a <i>de novo YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. There is, however, a <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> (~1%) to sibs based on the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#gabriele-devries.REF.rahbari.2016.126">Rahbari et al 2016</a>]. Given this risk, prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> may be considered.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="gabriele-devries.Resources"><h2 id="_gabriele-devries_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>National Center on Birth Defects and Developmental Disabilities</b></div><div>1600 Clifton Road</div><div>MS E-87</div><div>Atlanta GA 30333</div><div><b>Phone:</b> 800-232-4636 (toll-free); 888-232-6348 (TTY)</div><div><b>Email:</b> cdcinfo@cdc.gov</div><div><a href="http://www.cdc.gov/ncbddd/dd/ddmr.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>VOR: Speaking out for people with intellectual and developmental disabilities</b></div><div>836 South Arlington Heights Road, #351</div><div>Elk Grove Village IL 60007</div><div><b>Phone:</b> 877-399-4867</div><div><b>Fax:</b> 847-253-0675</div><div><b>Email:</b> info@vor.net</div><div><a href="http://www.vor.net/index.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.vor.net</a></div></li></ul></div><div id="gabriele-devries.Molecular_Genetics"><h2 id="_gabriele-devries_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gabriele-devries.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Gabriele-de Vries Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541730/table/gabriele-devries.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gabriele-devries.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gabriele-devries.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gabriele-devries.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gabriele-devries.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gabriele-devries.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gabriele-devries.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gabriele-devries.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7528" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>YY1</i></a></td><td headers="hd_b_gabriele-devries.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7528" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q32<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_gabriele-devries.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P25490" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transcriptional repressor protein YY1</a></td><td headers="hd_b_gabriele-devries.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=YY1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">YY1</a></td><td headers="hd_b_gabriele-devries.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=YY1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">YY1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gabriele-devries.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gabriele-devries.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Gabriele-de Vries Syndrome (<a href="/omim/600013,617557" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541730/table/gabriele-devries.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gabriele-devries.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600013" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600013</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSCRIPTION FACTOR YY1; YY1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617557" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617557</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GABRIELE-DE VRIES SYNDROME; GADEVS</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>YY1</i> is located on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 14:100,705,102-100,745,371 (hg19). The canonic transcript of <i>YY1</i>, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003403.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003403.4</a> (ENST00000262238.8), has five exons, spanning 6,697 bp and encoding 414 amino acids.</p><p>See <a href="/books/NBK541730/#gabriele-devries.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Gabriele-de Vries syndrome is caused by <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>YY1</i>, which can result from <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, or frameshift variants. Large deletions, including whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions, have also been reported. Missense variants are so far located in Zinc finger domains.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> YY1 is a Zn-finger protein [<a class="bk_pop" href="#gabriele-devries.REF.shi.1991.377">Shi et al 1991</a>] that mediates either gene activation or repression in an exquisitely context-dependent manner [<a class="bk_pop" href="#gabriele-devries.REF.atchison.2014.45">Atchison 2014</a>]. It regulates chromatin looping of transcriptional enhancers to their associated promoters [<a class="bk_pop" href="#gabriele-devries.REF.medvedovic.2013.229">Medvedovic et al 2013</a>, <a class="bk_pop" href="#gabriele-devries.REF.gerasimova.2015.1683">Gerasimova et al 2015</a>, <a class="bk_pop" href="#gabriele-devries.REF.weintraub.2017.1573">Weintraub et al 2017</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss-of-function variants result in halving of YY1 dosage [<a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al 2017</a>]. Disease-associated <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the YY1 Zn finger DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> completely impair its targeting function, as demonstrated by YY1 chromatin profiles (by ChIPseq) in individuals with either <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or missense variants that show the same widespread loss of genome-wide occupancy especially at low-occupancy sites [<a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al 2017</a>].</p><p>According to the capability of YY1 to mediate chromatin loops between enhancers and promoters [<a class="bk_pop" href="#gabriele-devries.REF.medvedovic.2013.229">Medvedovic et al 2013</a>, <a class="bk_pop" href="#gabriele-devries.REF.gerasimova.2015.1683">Gerasimova et al 2015</a>, <a class="bk_pop" href="#gabriele-devries.REF.weintraub.2017.1573">Weintraub et al 2017</a>], individuals harboring <i>YY1</i> pathogenic variants display an extensive loss of H3K27Ac on YY1-bound enhancers, thus characterizing Gabriele-de Vries syndrome as an enhanceropathy. The intellectual disability, a foundational <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> shared across all individuals with Gabriele-de Vries syndrome, is thus likely caused by failures in orchestrating the stages of neural development that are most sensitive to <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> regulation alterations caused by mutations in chromatin and transcriptional regulators [<a class="bk_pop" href="#gabriele-devries.REF.gabriele.2018.306">Gabriele et al 2018</a>].</p><p>In support of this hypothesis, <i>YY1</i> knockdown was shown to negatively affect enhancer-promoter interactions of key genes in neuronal progenitor cells [<a class="bk_pop" href="#gabriele-devries.REF.beagan.2017.1139">Beagan et al 2017</a>]. In addition, <i>YY1</i> has already been implicated as key regulator in several processes pertaining to nervous system development and function, as extensively reviewed elsewhere [<a class="bk_pop" href="#gabriele-devries.REF.he.2008.1493">He &#x00026; Casaccia-Bonnefil 2008</a>]. Notably, the neurodevelopmental <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Gabriele-de Vries syndrome is recapitulated in a <i>Yy1</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> mouse model, which features growth retardation and neurulation defects [<a class="bk_pop" href="#gabriele-devries.REF.donohoe.1999.7237">Donohoe et al 1999</a>]. Finally, the myelination deficits observed in patients afford pathophysiologic relevance to the myelination defects that follow conditional <i>Yy1</i> ablation in oligodendrocyte as a result of impaired differentiation [<a class="bk_pop" href="#gabriele-devries.REF.he.2007.217">He et al 2007</a>].</p><div id="gabriele-devries.Cancer_and_Benign_Tumor"><h3>Cancer and Benign Tumors</h3><p>YY1 is overexpressed in several <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> tumors including hepatocellular carcinoma [<a class="bk_pop" href="#gabriele-devries.REF.zhang.2012.1069">Zhang et al 2012</a>], breast, ovarian, brain, prostate, colon, and esophagus tumors, as well as osteosarcoma and melanoma, as recently extensively reviewed [<a class="bk_pop" href="#gabriele-devries.REF.khachigian.2018.460">Khachigian 2018</a>]. Its upregulation is correlated with poor prognosis [<a class="bk_pop" href="#gabriele-devries.REF.zaravinos.2010.512">Zaravinos &#x00026; Spandidos 2010</a>, <a class="bk_pop" href="#gabriele-devries.REF.cho.2017.49">Cho &#x00026; Bonavida 2017</a>, <a class="bk_pop" href="#gabriele-devries.REF.khachigian.2018.460">Khachigian 2018</a>]. Moreover, variants in threonine 372 (p.Thr372Arg), which increase its transcriptional activity, have been associated with the onset of sporadic insulinomas [<a class="bk_pop" href="#gabriele-devries.REF.cao.2013.2810">Cao et al 2013</a>, <a class="bk_pop" href="#gabriele-devries.REF.lichtenauer.2015.e776">Lichtenauer et al 2015</a>]. Consistent with the pleiotropic and exquisitely context-dependent aspects of its function, YY1 has also been found to promote the expression of tumor suppressors such as BRCA1 and p21 [<a class="bk_pop" href="#gabriele-devries.REF.khachigian.2018.460">Khachigian 2018</a>].</p></div></div><div id="gabriele-devries.References"><h2 id="_gabriele-devries_References_">References</h2><div id="gabriele-devries.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.atchison.2014.45">Atchison ML. Function of YY1 in long-distance DNA interactions. <span><span class="ref-journal">Front Immunol. </span>2014;<span class="ref-vol">5</span>:45.</span> [<a href="/pmc/articles/PMC3918653/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3918653</span></a>] [<a href="/pubmed/24575094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24575094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.beagan.2017.1139">Beagan JA, Duong MT, Titus KR, Zhou L, Cao Z, Ma J, Lachanski CV, Gillis DR, Phillips-Cremins JE. YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment. <span><span class="ref-journal">Genome Res. </span>2017;<span class="ref-vol">27</span>:1139–52.</span> [<a href="/pmc/articles/PMC5495066/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5495066</span></a>] [<a href="/pubmed/28536180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28536180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.cao.2013.2810">Cao Y, Gao Z, Li L, Jiang X, Shan A, Cai J, Peng Y, Li Y, Jiang X, Huang X, Wang J, Wei Q, Qin G, Zhao J, Jin X, Liu L, Li Y, Wang W, Wang J, Ning G. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. <span><span class="ref-journal">Nat Commun. </span>2013;<span class="ref-vol">4</span>:2810.</span> [<a href="/pubmed/24326773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24326773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.cho.2017.49">Cho AA, Bonavida B. Targeting the overexpressed YY1 in cancer inhibits EMT and metastasis. <span><span class="ref-journal">Crit Rev Oncog. </span>2017;<span class="ref-vol">22</span>:49–61.</span> [<a href="/pmc/articles/PMC5955615/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5955615</span></a>] [<a href="/pubmed/29604936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29604936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.donohoe.1999.7237">Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. <span><span class="ref-journal">Mol Cell Biol. </span>1999;<span class="ref-vol">19</span>:7237–44.</span> [<a href="/pmc/articles/PMC84716/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC84716</span></a>] [<a href="/pubmed/10490658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10490658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.gabriele.2018.306">Gabriele M, Lopez Tobon A, D'Agostino G, Testa G. The chromatin basis of neurodevelopmental disorders: rethinking dysfunction along the molecular and temporal axes. <span><span class="ref-journal">Prog Neuropsychopharmacol Biol Psychiatry. </span>2018;<span class="ref-vol">84</span>:306–27.</span> [<a href="/pubmed/29309830" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29309830</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.gabriele.2017.907">Gabriele M, Vulto-van Silfhout AT, Germain PL, Vitriolo A, Kumar R, Douglas E, Haan E, Kosaki K, Takenouchi T, Rauch A, Steindl K, Frengen E, Misceo D, Pedurupillay CRJ, Stromme P, Rosenfeld JA, Shao Y, Craigen WJ, Schaaf CP, Rodriguez-Buritica D, Farach L, Friedman J, Thulin P, McLean SD, Nugent KM, Morton J, Nicholl J, Andrieux J, Stray-Pedersen A, Chambon P, Patrier S, Lynch SA, Kjaergaard S, T&#x000f8;rring PM, Brasch-Andersen C, Ronan A, van Haeringen A, Anderson PJ, Powis Z, Brunner HG, Pfundt R, Schuurs-Hoeijmakers JHM, van Bon BWM, Lelieveld S, Gilissen C, Nillesen WM, Vissers LELM, Gecz J, Koolen DA, Testa G, de Vries BBA. YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. <span><span class="ref-journal">Am J Hum Genet. </span>2017;<span class="ref-vol">100</span>:907–25.</span> [<a href="/pmc/articles/PMC5473733/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5473733</span></a>] [<a href="/pubmed/28575647" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28575647</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.gerasimova.2015.1683">Gerasimova T, Guo C, Ghosh A, Qiu X, Montefiori L, Verma-Gaur J, Choi NM, Feeney AJ, Sen R. A structural hierarchy mediated by multiple nuclear factors establishes IgH locus conformation. <span><span class="ref-journal">Genes Dev. </span>2015;<span class="ref-vol">29</span>:1683–95.</span> [<a href="/pmc/articles/PMC4561478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4561478</span></a>] [<a href="/pubmed/26302788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26302788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.he.2008.1493">He Y, Casaccia-Bonnefil P. The Yin and Yang of YY1 in the nervous system. <span><span class="ref-journal">J Neurochem. </span>2008;<span class="ref-vol">106</span>:1493–502.</span> [<a href="/pmc/articles/PMC2642738/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2642738</span></a>] [<a href="/pubmed/18485096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18485096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.he.2007.217">He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA, Casaccia-Bonnefil P. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. <span><span class="ref-journal">Neuron. </span>2007;<span class="ref-vol">55</span>:217–30.</span> [<a href="/pmc/articles/PMC2034312/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2034312</span></a>] [<a href="/pubmed/17640524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17640524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.khachigian.2018.460">Khachigian LM. The Yin and Yang of YY1 in tumor growth and suppression. <span><span class="ref-journal">Int J Cancer. </span>2018;<span class="ref-vol">143</span>:460–5.</span> [<a href="/pubmed/29322514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29322514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.lichtenauer.2015.e776">Lichtenauer UD, Di Dalmazi G, Slater EP, Wieland T, Kuebart A, Schmittfull A, Schwarzmayr T, Diener S, Wiese D, Thasler WE, Reincke M, Meitinger T, Schott M, Fassnacht M, Bartsch DK, Strom TM, Beuschlein F. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2015;<span class="ref-vol">100</span>:E776–82.</span> [<a href="/pubmed/25763608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25763608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.medvedovic.2013.229">Medvedovic J, Ebert A, Tagoh H, Tamir IM, Schwickert TA, Novatchkova M, Sun Q, Huis In 't Veld PJ, Guo C, Yoon HS, Denizot Y, Holwerda SJ, de Laat W, Cogn&#x000e9; M, Shi Y, Alt FW, Busslinger M. Flexible long-range loops in the VH gene region of the Igh locus facilitate the generation of a diverse antibody repertoire. <span><span class="ref-journal">Immunity. </span>2013;<span class="ref-vol">39</span>:229–44.</span> [<a href="/pmc/articles/PMC4810778/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4810778</span></a>] [<a href="/pubmed/23973221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23973221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.shi.1991.377">Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Kr&#x000fc;ppel-related protein, and relief of repression by adenovirus E1A protein. <span><span class="ref-journal">Cell. </span>1991;<span class="ref-vol">67</span>:377–88.</span> [<a href="/pubmed/1655281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1655281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.vissers.2010.1109">Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, de Vries BB, Brunner HG, Veltman JA. A de novo paradigm for mental retardation. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:1109–12.</span> [<a href="/pubmed/21076407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21076407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.weintraub.2017.1573">Weintraub AS, Li CH, Zamudio AV, Sigova AA, Hannett NM, Day DS, Abraham BJ, Cohen MA, Nabet B, Buckley DL, Guo YE, Hnisz D, Jaenisch R, Bradner JE, Gray NS, Young RA. YY1 is a structural regulator of enhancer-promoter loops. <span><span class="ref-journal">Cell. </span>2017;<span class="ref-vol">171</span>:1573–88.e28.</span> [<a href="/pmc/articles/PMC5785279/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5785279</span></a>] [<a href="/pubmed/29224777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29224777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.zaravinos.2010.512">Zaravinos A, Spandidos DA. Yin yang 1 expression in human tumors. <span><span class="ref-journal">Cell Cycle. </span>2010;<span class="ref-vol">9</span>:512–22.</span> [<a href="/pubmed/20081375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20081375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gabriele-devries.REF.zhang.2012.1069">Zhang S, Jiang T, Feng L, Sun J, Lu H, Wang Q, Pan M, Huang D, Wang X, Wang L, Jin H. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. <span><span class="ref-journal">J Mol Med (Berl). </span>2012;<span class="ref-vol">90</span>:1069–77.</span> [<a href="/pubmed/22391813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22391813</span></a>]</div></li></ul></div></div><div id="gabriele-devries.Chapter_Notes"><h2 id="_gabriele-devries_Chapter_Notes_">Chapter Notes</h2><div id="gabriele-devries.Author_Notes"><h3>Author Notes</h3><p>The authors also recommend the following resource: <a href="http://humandiseasegenes.nl/yy1/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Disease Genes Website Series: <i>YY1</i></a>.</p><p>To gain further insight, and expand the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of pathogenic variants within the complete <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of the <i>YY1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, and to carry on research into the underlying mechanism of this disorder, parents and physicians are encouraged to visit the above-mentioned gene website and submit clinical information on newly diagnosed individuals.</p></div><div id="gabriele-devries.Acknowledgments"><h3>Acknowledgments</h3><p>We acknowledge all individuals and their parents who participated in the study described in <a class="bk_pop" href="#gabriele-devries.REF.gabriele.2017.907">Gabriele et al [2017]</a>, along with the agencies that funded that work.</p></div><div id="gabriele-devries.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 May 2019 (ma) Review posted live</div></li><li class="half_rhythm"><div>23 April 2018 (gt, bdv) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK541730</span><span class="label">PMID: <a href="/pubmed/31145572" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31145572</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/drd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gaucher/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK541730&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK541730/?report=reader">PubReader</a></li><li><a href="/books/NBK541730/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK541730" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK541730" style="display:none" title="Cite this Page"><div class="bk_tt">Nabais Sá MJ, Gabriele M, Testa G, et al. Gabriele-de Vries Syndrome. 2019 May 30. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK541730/pdf/Bookshelf_NBK541730.pdf">PDF version of this page</a> (459K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gabriele-devries.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gabriele-devries.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gabriele-devries.Clinical_Characteristic" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gabriele-devries.Genetically_Related_All" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#gabriele-devries.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gabriele-devries.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gabriele-devries.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gabriele-devries.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gabriele-devries.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gabriele-devries.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gabriele-devries.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7528[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">YY1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4777300" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4777300" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4777300" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4777300" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30896913" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RERE</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RERE</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scott DA, Sherr EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29023086" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SATB2-</i>Associated Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SATB2-</i>Associated Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Zarate YA, Kaylor J, Fish J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301783" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Koolen-de Vries Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Koolen-de Vries Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Koolen DA, Morgan A, de Vries BBA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30702837" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CDK13</i>-Related Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CDK13</i>-Related Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bostwick B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29851452" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2B</i>-Related Neurodevelopmental Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2B</i>-Related Neurodevelopmental Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Platzer K, Lemke JR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31145572" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31145572" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04186039a66ee2ba3ede95">Gabriele-de Vries Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Gabriele-de Vries Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:18:08-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A41D6E04093C1000000000678026A&amp;ncbi_session=CE8A41D6E0418601_1656SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK541730%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK541730&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK541730/&amp;ncbi_pagename=Gabriele-de Vries Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A41D6E0418601_1656SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>